Can hyperbaric oxygen therapy reduce breast cancer treatment-related lymphedema? A pilot study.
Identifieur interne : 001C79 ( Ncbi/Merge ); précédent : 001C78; suivant : 001C80Can hyperbaric oxygen therapy reduce breast cancer treatment-related lymphedema? A pilot study.
Auteurs : Jane Teas [États-Unis] ; Joan E. Cunningham ; Lindsie Cone ; Kel Jansen ; Senthil K. Raghavan ; Daniela K. Nitcheva ; Dawen Xie ; William M. ButlerSource :
- Journal of women's health (2002) [ 1540-9996 ] ; 2004.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Bras (anatomopathologie), Facteur de croissance endothéliale vasculaire de type A (sang), Facteur de croissance endothéliale vasculaire de type C (sang), Facteurs temps, Femelle, Humains, Intervalles de confiance, Lymphadénectomie (effets indésirables), Lymphoedème (), Lymphoedème (sang), Lymphoedème (étiologie), Mastectomie (effets indésirables), Odds ratio, Oxygénation hyperbare (), Projets pilotes, Radiothérapie adjuvante (effets indésirables), Résultat thérapeutique, Sujet âgé, Tumeurs du sein (), Tumeurs du sein (radiothérapie).
- MESH :
- anatomopathologie : Bras.
- effets indésirables : Lymphadénectomie, Mastectomie, Radiothérapie adjuvante.
- radiothérapie : Tumeurs du sein.
- sang : Facteur de croissance endothéliale vasculaire de type A, Facteur de croissance endothéliale vasculaire de type C, Lymphoedème.
- étiologie : Lymphoedème.
- Adulte d'âge moyen, Facteurs temps, Femelle, Humains, Intervalles de confiance, Lymphoedème, Odds ratio, Oxygénation hyperbare, Projets pilotes, Résultat thérapeutique, Sujet âgé, Tumeurs du sein.
English descriptors
- KwdEn :
- Aged, Arm (pathology), Breast Neoplasms (radiotherapy), Breast Neoplasms (surgery), Breast Neoplasms (therapy), Confidence Intervals, Female, Humans, Hyperbaric Oxygenation (methods), Lymph Node Excision (adverse effects), Lymphedema (blood), Lymphedema (etiology), Lymphedema (therapy), Mastectomy (adverse effects), Middle Aged, Odds Ratio, Pilot Projects, Radiotherapy, Adjuvant (adverse effects), Time Factors, Treatment Outcome, Vascular Endothelial Growth Factor A (blood), Vascular Endothelial Growth Factor C (blood).
- MESH :
- chemical , blood : Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factor C.
- adverse effects : Lymph Node Excision, Mastectomy, Radiotherapy, Adjuvant.
- blood : Lymphedema.
- etiology : Lymphedema.
- methods : Hyperbaric Oxygenation.
- pathology : Arm.
- radiotherapy : Breast Neoplasms.
- surgery : Breast Neoplasms.
- therapy : Breast Neoplasms, Lymphedema.
- Aged, Confidence Intervals, Female, Humans, Middle Aged, Odds Ratio, Pilot Projects, Time Factors, Treatment Outcome.
Abstract
Arm lymphedema after surgery or radiation for breast cancer is common, causing pain and limitation of activities. Previous reports of hyperbaric oxygen (HBO) therapy for breast edema led us to consider the use of HBO therapy for arm lymphedema.
DOI: 10.1089/jwh.2004.13.1008
PubMed: 15665658
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003E00
- to stream PubMed, to step Curation: 003E00
- to stream PubMed, to step Checkpoint: 003E00
Links to Exploration step
pubmed:15665658Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Can hyperbaric oxygen therapy reduce breast cancer treatment-related lymphedema? A pilot study.</title><author><name sortKey="Teas, Jane" sort="Teas, Jane" uniqKey="Teas J" first="Jane" last="Teas">Jane Teas</name><affiliation wicri:level="2"><nlm:affiliation>Department of Health Promotion Education and Behavior, Arnold School of Public Health, University of South Carolina and the South Carolina Cancer Center, Columbia, South Carolina, USA. jane.teas@palmettohealth.org</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Health Promotion Education and Behavior, Arnold School of Public Health, University of South Carolina and the South Carolina Cancer Center, Columbia, South Carolina</wicri:regionArea><placeName><region type="state">Caroline du Sud</region></placeName></affiliation></author><author><name sortKey="Cunningham, Joan E" sort="Cunningham, Joan E" uniqKey="Cunningham J" first="Joan E" last="Cunningham">Joan E. Cunningham</name></author><author><name sortKey="Cone, Lindsie" sort="Cone, Lindsie" uniqKey="Cone L" first="Lindsie" last="Cone">Lindsie Cone</name></author><author><name sortKey="Jansen, Kel" sort="Jansen, Kel" uniqKey="Jansen K" first="Kel" last="Jansen">Kel Jansen</name></author><author><name sortKey="Raghavan, Senthil K" sort="Raghavan, Senthil K" uniqKey="Raghavan S" first="Senthil K" last="Raghavan">Senthil K. Raghavan</name></author><author><name sortKey="Nitcheva, Daniela K" sort="Nitcheva, Daniela K" uniqKey="Nitcheva D" first="Daniela K" last="Nitcheva">Daniela K. Nitcheva</name></author><author><name sortKey="Xie, Dawen" sort="Xie, Dawen" uniqKey="Xie D" first="Dawen" last="Xie">Dawen Xie</name></author><author><name sortKey="Butler, William M" sort="Butler, William M" uniqKey="Butler W" first="William M" last="Butler">William M. Butler</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2004">2004</date><idno type="RBID">pubmed:15665658</idno><idno type="pmid">15665658</idno><idno type="doi">10.1089/jwh.2004.13.1008</idno><idno type="wicri:Area/PubMed/Corpus">003E00</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003E00</idno><idno type="wicri:Area/PubMed/Curation">003E00</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003E00</idno><idno type="wicri:Area/PubMed/Checkpoint">003E00</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003E00</idno><idno type="wicri:Area/Ncbi/Merge">001C79</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Can hyperbaric oxygen therapy reduce breast cancer treatment-related lymphedema? A pilot study.</title><author><name sortKey="Teas, Jane" sort="Teas, Jane" uniqKey="Teas J" first="Jane" last="Teas">Jane Teas</name><affiliation wicri:level="2"><nlm:affiliation>Department of Health Promotion Education and Behavior, Arnold School of Public Health, University of South Carolina and the South Carolina Cancer Center, Columbia, South Carolina, USA. jane.teas@palmettohealth.org</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Health Promotion Education and Behavior, Arnold School of Public Health, University of South Carolina and the South Carolina Cancer Center, Columbia, South Carolina</wicri:regionArea><placeName><region type="state">Caroline du Sud</region></placeName></affiliation></author><author><name sortKey="Cunningham, Joan E" sort="Cunningham, Joan E" uniqKey="Cunningham J" first="Joan E" last="Cunningham">Joan E. Cunningham</name></author><author><name sortKey="Cone, Lindsie" sort="Cone, Lindsie" uniqKey="Cone L" first="Lindsie" last="Cone">Lindsie Cone</name></author><author><name sortKey="Jansen, Kel" sort="Jansen, Kel" uniqKey="Jansen K" first="Kel" last="Jansen">Kel Jansen</name></author><author><name sortKey="Raghavan, Senthil K" sort="Raghavan, Senthil K" uniqKey="Raghavan S" first="Senthil K" last="Raghavan">Senthil K. Raghavan</name></author><author><name sortKey="Nitcheva, Daniela K" sort="Nitcheva, Daniela K" uniqKey="Nitcheva D" first="Daniela K" last="Nitcheva">Daniela K. Nitcheva</name></author><author><name sortKey="Xie, Dawen" sort="Xie, Dawen" uniqKey="Xie D" first="Dawen" last="Xie">Dawen Xie</name></author><author><name sortKey="Butler, William M" sort="Butler, William M" uniqKey="Butler W" first="William M" last="Butler">William M. Butler</name></author></analytic><series><title level="j">Journal of women's health (2002)</title><idno type="ISSN">1540-9996</idno><imprint><date when="2004" type="published">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Arm (pathology)</term><term>Breast Neoplasms (radiotherapy)</term><term>Breast Neoplasms (surgery)</term><term>Breast Neoplasms (therapy)</term><term>Confidence Intervals</term><term>Female</term><term>Humans</term><term>Hyperbaric Oxygenation (methods)</term><term>Lymph Node Excision (adverse effects)</term><term>Lymphedema (blood)</term><term>Lymphedema (etiology)</term><term>Lymphedema (therapy)</term><term>Mastectomy (adverse effects)</term><term>Middle Aged</term><term>Odds Ratio</term><term>Pilot Projects</term><term>Radiotherapy, Adjuvant (adverse effects)</term><term>Time Factors</term><term>Treatment Outcome</term><term>Vascular Endothelial Growth Factor A (blood)</term><term>Vascular Endothelial Growth Factor C (blood)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Bras (anatomopathologie)</term><term>Facteur de croissance endothéliale vasculaire de type A (sang)</term><term>Facteur de croissance endothéliale vasculaire de type C (sang)</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Intervalles de confiance</term><term>Lymphadénectomie (effets indésirables)</term><term>Lymphoedème ()</term><term>Lymphoedème (sang)</term><term>Lymphoedème (étiologie)</term><term>Mastectomie (effets indésirables)</term><term>Odds ratio</term><term>Oxygénation hyperbare ()</term><term>Projets pilotes</term><term>Radiothérapie adjuvante (effets indésirables)</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Tumeurs du sein ()</term><term>Tumeurs du sein (radiothérapie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Vascular Endothelial Growth Factor A</term><term>Vascular Endothelial Growth Factor C</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lymph Node Excision</term><term>Mastectomy</term><term>Radiotherapy, Adjuvant</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Bras</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Lymphadénectomie</term><term>Mastectomie</term><term>Radiothérapie adjuvante</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Hyperbaric Oxygenation</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Arm</term></keywords><keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Facteur de croissance endothéliale vasculaire de type A</term><term>Facteur de croissance endothéliale vasculaire de type C</term><term>Lymphoedème</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Breast Neoplasms</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Confidence Intervals</term><term>Female</term><term>Humans</term><term>Middle Aged</term><term>Odds Ratio</term><term>Pilot Projects</term><term>Time Factors</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Intervalles de confiance</term><term>Lymphoedème</term><term>Odds ratio</term><term>Oxygénation hyperbare</term><term>Projets pilotes</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Tumeurs du sein</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Arm lymphedema after surgery or radiation for breast cancer is common, causing pain and limitation of activities. Previous reports of hyperbaric oxygen (HBO) therapy for breast edema led us to consider the use of HBO therapy for arm lymphedema.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15665658</PMID><DateCreated><Year>2005</Year><Month>01</Month><Day>24</Day></DateCreated><DateCompleted><Year>2005</Year><Month>03</Month><Day>04</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1540-9996</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>9</Issue><PubDate><Year>2004</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of women's health (2002)</Title><ISOAbbreviation>J Womens Health (Larchmt)</ISOAbbreviation></Journal><ArticleTitle>Can hyperbaric oxygen therapy reduce breast cancer treatment-related lymphedema? A pilot study.</ArticleTitle><Pagination><MedlinePgn>1008-18</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Arm lymphedema after surgery or radiation for breast cancer is common, causing pain and limitation of activities. Previous reports of hyperbaric oxygen (HBO) therapy for breast edema led us to consider the use of HBO therapy for arm lymphedema.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Ten healthy postmenopausal women (age 58 +/- 5.7 years) with persistent (9.4 years +/- 9.1 years) arm lymphedema following breast cancer surgery and radiation (n = 10) plus chemotherapy (n = 7) received 20 HBO treatments (90 minutes at 2.0 ATA five times a week for 4 weeks). End points included changes in upper extremity volume, platelet counts, plasma levels of vascular endothelial growth factor (VEGF), and lymph angiogenic-associated vascular endothelial growth factor-C (VEGF-C). Lymphedema volume (LV) was defined as the volume of the unaffected arm subtracted from the volume of the affected arm.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We observed a 38% average reduction in hand lymphedema (-7.4 ml, 11.6 SD, range -30-+8 ml, p = 0.076, 95% confidence interval -15.7-0.9 ml) at the end of HBO, which was independent of changes in body weight. For those who benefited (n = 8), the reduction was persistent from the end of treatment to a final measurement an average of 14.2 months after the last HBO treatment. However, total LV did not change significantly. VEGF-C increased from baseline (p = 0.004) before treatment 20, suggesting HBO had begun to stimulate this growth factor.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Future studies should explore the effects of a greater number of HBO treatments on lymphedema, with more patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Teas</LastName><ForeName>Jane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Health Promotion Education and Behavior, Arnold School of Public Health, University of South Carolina and the South Carolina Cancer Center, Columbia, South Carolina, USA. jane.teas@palmettohealth.org</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cunningham</LastName><ForeName>Joan E</ForeName><Initials>JE</Initials></Author><Author ValidYN="Y"><LastName>Cone</LastName><ForeName>Lindsie</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Jansen</LastName><ForeName>Kel</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Raghavan</LastName><ForeName>Senthil K</ForeName><Initials>SK</Initials></Author><Author ValidYN="Y"><LastName>Nitcheva</LastName><ForeName>Daniela K</ForeName><Initials>DK</Initials></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Dawen</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Butler</LastName><ForeName>William M</ForeName><Initials>WM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Womens Health (Larchmt)</MedlineTA><NlmUniqueID>101159262</NlmUniqueID><ISSNLinking>1540-9996</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D042461">Vascular Endothelial Growth Factor A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D042582">Vascular Endothelial Growth Factor C</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001132" MajorTopicYN="N">Arm</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016001" MajorTopicYN="N">Confidence Intervals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006931" MajorTopicYN="Y">Hyperbaric Oxygenation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008408" MajorTopicYN="N">Mastectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018714" MajorTopicYN="N">Radiotherapy, Adjuvant</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042461" MajorTopicYN="N">Vascular Endothelial Growth Factor A</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042582" MajorTopicYN="N">Vascular Endothelial Growth Factor C</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>1</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>3</Month><Day>5</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>1</Month><Day>25</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15665658</ArticleId><ArticleId IdType="doi">10.1089/jwh.2004.13.1008</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Caroline du Sud</li></region></list><tree><noCountry><name sortKey="Butler, William M" sort="Butler, William M" uniqKey="Butler W" first="William M" last="Butler">William M. Butler</name><name sortKey="Cone, Lindsie" sort="Cone, Lindsie" uniqKey="Cone L" first="Lindsie" last="Cone">Lindsie Cone</name><name sortKey="Cunningham, Joan E" sort="Cunningham, Joan E" uniqKey="Cunningham J" first="Joan E" last="Cunningham">Joan E. Cunningham</name><name sortKey="Jansen, Kel" sort="Jansen, Kel" uniqKey="Jansen K" first="Kel" last="Jansen">Kel Jansen</name><name sortKey="Nitcheva, Daniela K" sort="Nitcheva, Daniela K" uniqKey="Nitcheva D" first="Daniela K" last="Nitcheva">Daniela K. Nitcheva</name><name sortKey="Raghavan, Senthil K" sort="Raghavan, Senthil K" uniqKey="Raghavan S" first="Senthil K" last="Raghavan">Senthil K. Raghavan</name><name sortKey="Xie, Dawen" sort="Xie, Dawen" uniqKey="Xie D" first="Dawen" last="Xie">Dawen Xie</name></noCountry><country name="États-Unis"><region name="Caroline du Sud"><name sortKey="Teas, Jane" sort="Teas, Jane" uniqKey="Teas J" first="Jane" last="Teas">Jane Teas</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C79 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001C79 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:15665658
|texte= Can hyperbaric oxygen therapy reduce breast cancer treatment-related lymphedema? A pilot study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:15665658" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |